ClinicalTrials.Veeva
Menu

Find clinical trials for Leukemia in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Myeloid Leukemia
Acute Myeloid Leukemia
Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Myelodysplastic Syndromes

Leukemia trials near Warszawa, Mazowieckie, POL:

RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome

This first-in-human study will evaluate RVU120 (SEL120), a novel small molecule CDK8/19 inhibitor, in patients with Acute Myeloid Leukemia (...

Active, not recruiting
Acute Myeloid Leukemia
High-risk Myelodysplastic Syndrome
Drug: RVU120(SEL120)

Phase 1

Ryvu Therapeutics

Warsaw, Poland and 9 other locations

The purpose of this study is to characterize the efficacy of ponatinib administered in 3 starting doses (45 mg, 30 mg, and 15 mg daily) in participan...

Active, not recruiting
Myeloid Leukemia, Chronic, Chronic Phase
Drug: Ponatinib

Phase 2

Takeda
Takeda

Warszawa, Mazowieckie, Poland and 85 other locations

The purpose of this study is to determine whether the combination of pevonedistat and azacitidine improves event-free survival (EFS) when compared wi...

Active, not recruiting
Leukemia, Myeloid, Acute
Leukemia, Myelomonocytic, Chronic
Drug: Pevonedistat
Drug: Azacitidine

Phase 3

Takeda
Takeda

Warszawa, Mazowieckie, Poland and 240 other locations

or asciminib 60mg+imatinib versus continued imatinib and versus nilotinib versus asciminib 80mg in pre-treated patients with Chronic Myeloid Leukemia...

Active, not recruiting
Chronic Myelogenous Leukemia
Leukemia, Myeloid Chronic
Drug: Asciminib add-on
Drug: Nilotinib

Phase 2

Novartis
Novartis

Warszawa, Poland and 28 other locations

of the study is to characterize safety and tolerability of cusatuzumab in combination with various therapies used to treat acute myeloid leukemia...

Active, not recruiting
Leukemia, Myeloid, Acute
Drug: Azacitidine
Drug: Venetoclax

Phase 1

OncoVerity

Warszawa, Poland and 22 other locations

This is a Phase 1/2, multicenter, open-label, dose-escalation study that will determine the MTD and RP2D of L-Annamycin in combination with cytarabin...

Enrolling
Leukemia, Myeloid, Acute
Drug: Liposomal Annamycin
Drug: Cytarabine

Phase 1, Phase 2

Moleculin Biotech

Warsaw, Poland and 8 other locations

Locations recently updated

study is to compare the efficacy of sonrotoclax plus zanubrutinib versus venetoclax plus obinutuzumab in participants with chronic lymphocytic leukemia...

Enrolling
CLL
Drug: Zanubrutinib
Drug: Sonrotoclax

Phase 3

BeiGene
BeiGene

Warszawa, Poland and 175 other locations

The purpose of the study is to optimize the treatment of asciminib in patients with chronic myelogenous leukemia in chronic phase (CML-CP) p...

Active, not recruiting
Chronic Myelogenous Leukemia
Drug: ABL001 200mg QD
Drug: ABL001 40mg BID

Phase 3

Novartis
Novartis

Warszawa, Poland and 47 other locations

This is a clinical study for adult patients who have recently been diagnosed with acute myeloid leukemia or AML. AML is a type of cancer. It...

Active, not recruiting
Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
Acute Myeloid Leukemia (AML)
Drug: azacitidine
Drug: gilteritinib

Phase 3

Astellas
Astellas

Warszawa, Mazowieckie, Poland and 110 other locations

The main purpose of the study was to investigate whether nilotinib treatment can be safely suspended with no recurrence of CML in selected patients w...

Active, not recruiting
Chronic Myelogenous Leukemia
Drug: Nilotinib followed by treatment-free

Phase 2

Novartis
Novartis

Warszawa, Poland and 114 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems